- Home
- ILPT vs FDMT Comparison
ILPT vs FDMT Comparison
Compare ILPT & FDMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ILPT
- FDMT
- Stock Information
- Founded
- ILPT 2017
- FDMT 2013
- Country
- ILPT United States
- FDMT United States
- Employees
- ILPT N/A
- FDMT N/A
- Industry
- ILPT Real Estate Investment Trusts
- FDMT Biotechnology: Pharmaceutical Preparations
- Sector
- ILPT Real Estate
- FDMT Health Care
- Exchange
- ILPT Nasdaq
- FDMT Nasdaq
- Market Cap
- ILPT 366.2M
- FDMT 391.8M
- IPO Year
- ILPT 2018
- FDMT 2020
- Fundamental
- Price
- ILPT $5.28
- FDMT $11.50
- Analyst Decision
- ILPT
- FDMT Strong Buy
- Analyst Count
- ILPT 0
- FDMT 9
- Target Price
- ILPT N/A
- FDMT $30.11
- AVG Volume (30 Days)
- ILPT 264.0K
- FDMT 933.7K
- Earning Date
- ILPT 10-28-2025
- FDMT 11-07-2025
- Dividend Yield
- ILPT 3.79%
- FDMT N/A
- EPS Growth
- ILPT N/A
- FDMT N/A
- EPS
- ILPT N/A
- FDMT N/A
- Revenue
- ILPT $445,459,000.00
- FDMT $33,000.00
- Revenue This Year
- ILPT $3.44
- FDMT $9,656.76
- Revenue Next Year
- ILPT $1.78
- FDMT N/A
- P/E Ratio
- ILPT N/A
- FDMT N/A
- Revenue Growth
- ILPT 1.08
- FDMT N/A
- 52 Week Low
- ILPT $2.45
- FDMT $2.24
- 52 Week High
- ILPT $6.57
- FDMT $12.34
- Technical
- Relative Strength Index (RSI)
- ILPT 38.46
- FDMT 63.45
- Support Level
- ILPT $4.92
- FDMT $11.09
- Resistance Level
- ILPT $6.08
- FDMT $12.34
- Average True Range (ATR)
- ILPT 0.22
- FDMT 0.90
- MACD
- ILPT -0.03
- FDMT 0.01
- Stochastic Oscillator
- ILPT 31.03
- FDMT 71.43
About ILPT Industrial Logistics Properties Trust of Beneficial Interest
Industrial Logistics Properties Trust is a real estate investment trust. It owns and leases industrial and logistics properties throughout the United States. The company's investment portfolio includes industrial lands in Hawaii and industrial and logistics properties in other states. Rental revenue is earned from Hawaii Properties and Mainland Properties.
About FDMT 4D Molecular Therapeutics Inc.
4D Molecular Therapeutics Inc is a clinical-stage gene therapy company engaged in the development of product candidates using targeted and evolved AAV vectors. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-125, 4D-110, and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector) 4D-310.